ATF2 and head and neck squamous cell carcinoma: Rigosertib enhanced the phosphorylation of JNK and ATF-2 in all three HNSCC cell lines examined, indicating activation of cellular stress response through JNK signaling in both HPV(+) and HPV(−) cell lines.